Dr. Jay Lance Lafleur, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Blossom St, Suite 120, Webster, TX 77598 Phone: 713-973-7246 |
Rachel Austin Thompson, AGACNP Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 E Medical Center Blvd, Webster, TX 77598 Phone: 832-930-9001 |
Dr. Michael Scott Gorback, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 17099 Texas Ave, 300, Webster, TX 77598 Phone: 281-554-3400 Fax: 281-554-3404 |
News Archive
UMass Memorial Health Care is undertaking an electronic medical record integration project of incredible scope. Known as Cornerstone, the project is a multi-year, multi-entity corporate initiative to implement common patient clinical and financial systems and to reduce variability in processes and workflows across the system. Currently in full design and implementation mode and continuing over the next four years, the way UMass Memorial collects, views, shares, manages, and interacts with all patient information will drastically change and improve.
Couples who use fertility awareness-based methods of family planning have sex just as often as couples who use other contraceptive methods - they just time it differently, according to a new Georgetown University Institute for Reproductive Health study to be published in a forthcoming edition of the Journal of Biosocial Science.
Results from an Italian study show that atopy patch tests could predict oral tolerance in children with gastrointestinal symptoms related to non-IgE-mediated cow's milk allergy.
The promises that were made to sell Obamacare -; that it wouldn't disrupt people's previous health care arrangements and that premiums would go down -; are now being exposed for the cheap and deceptive sales pitch they were. It may be tempting for some to brush all this aside as standard politics.
The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology.
› Verified 1 days ago